Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 4

1.

Different HER2 protein expression profiles aid in the histologic differential diagnosis between urothelial carcinoma in situ (CIS) and non-CIS conditions (dysplasia and reactive atypia) of the urinary bladder mucosa.

Gunia S, Koch S, Hakenberg OW, May M, Kakies C, Erbersdobler A.

Am J Clin Pathol. 2011 Dec;136(6):881-8. doi: 10.1309/AJCPKUZ69LXZGFEA.

PMID:
22095373
[PubMed - indexed for MEDLINE]
Free Article
2.

[Recent advances in diagnosis of flat lesions of urinary bladder].

Cheng L, Xu JW, Teng XD.

Zhonghua Bing Li Xue Za Zhi. 2010 Sep;39(9):577-81. Review. Chinese. No abstract available.

PMID:
21092582
[PubMed - indexed for MEDLINE]
3.

Carcinoma in situ of the urinary bladder: review of clinicopathologic characteristics with an emphasis on aspects related to molecular diagnostic techniques and prognosis.

Nese N, Gupta R, Bui MH, Amin MB.

J Natl Compr Canc Netw. 2009 Jan;7(1):48-57. Review.

PMID:
19176205
[PubMed - indexed for MEDLINE]
4.

Urothelial carcinoma in situ of the bladder.

Humphrey PA.

J Urol. 2012 Mar;187(3):1057-8. doi: 10.1016/j.juro.2011.12.020. Epub 2012 Jan 21. Review. No abstract available.

PMID:
22265997
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk